Generic Name and Formulations:
Nitroglycerin 0.3mg, 0.4mg, 0.6mg; sublingual tabs.
Indications for NITROSTAT:
Acute relief of angina attack. Prophylaxis of angina pectoris.
Treatment: 1 tab sublingually or in buccal pouch at onset, may repeat in 5 mins; max 3 tabs in 15 mins. Prophylaxis: 5–10 mins before activity.
Early MI. Severe anemia. Increased intracranial pressure. Concomitant PDE-5 inhibitors (eg, sildenafil, tadalafil, vardenafil).
Acute MI, CHF: monitor. Hypotensive or volume depleted. Hypertrophic cardiomyopathy. Avoid abrupt cessation. Discontinue if blurred vision or dry mouth occurs. Use lowest effective dose. Elderly. Pregnancy (Cat.B). Nursing mothers.
See Contraindications. Hypotension potentiated by PDE-5 inhibitors, calcium channel blockers, alcohol, aspirin. May antagonize alteplase, heparin. Drugs that cause dry mouth (eg, tricyclics, anticholinergics) may interfere with sublingual dissolution. Avoid ergotamine and related drugs. Tolerance to other forms of nitrates may blunt effects. May interfere with cholesterol tests.
Headache, vertigo, weakness, palpitation, orthostatic hypotension, tachycardia, syncope, flushing, rash, exfoliative dermatitis.
Tabs 0.4mg—4 x 25, 100; 0.3mg, 0.6mg—100
- 0.4mg sublinguals (Qty:25)
- appx. price $31.00
Sign Up for Free e-newsletters
- Researchers Get Closer to Testing Anti-Aging Pill in Humans
- Verapamil May Help Lower Glucose Levels in Diabetic Patients
- Alzheimer's Drug Shortage Resolved
- Recommendations for Management of Recurrent UTI in Older Men
- Impacts of Low/High Glycemic Foods to Postprandial Blood Glucose in Type 1 Diabetes